About Akili EndeavorOTC
EndeavorOTC is an FDA-cleared over-the-counter digital therapeutic for adults with ADHD, delivered through an engaging video game experience. Unlike the prescription EndeavorRx for children, EndeavorOTC is indicated for adults with primarily inattentive or combined-type ADHD and can be obtained without a prescription. The game uses the same neuroscience-based approach as EndeavorRx, employing sensory stimuli and motor challenges to target brain areas key to attention function. Users navigate courses, collect targets, and avoid obstacles while being challenged to multitask and ignore distractions. FDA cleared in June 2024, EndeavorOTC represents the first OTC digital therapeutic for adult ADHD.
Best For
- • Adult psychiatrists and primary care providers whose adult ADHD patients may benefit from accessible
- • non-pharmacological attention training
Not Ideal For
- • Patients with photosensitive epilepsy or conditions that preclude video game use
- • or those seeking pediatric ADHD treatment (use EndeavorRx)
Pricing
Pricing not available
Compliance & Security
Always verify compliance directly with the vendor.
Target Audience
Roles
Settings
Related Tools
EndeavorRx
FDA-approved video game treatment for pediatric ADHD
Akili Interactive (EndeavorRx, EndeavorOTC)
First FDA-cleared video game digital therapeutic for ADHD in children and adults.
Big Health (Sleepio, Daylight)
First FDA-cleared DTx for anxiety (DaylightRx) and insomnia (SleepioRx) with Medicare coverage.
Blueprint
Free EHR with AI assistant and measurement-based care for therapists.